Hot Topics

Screens for Focal Benefits

When Genescient has used its two-way genomic screen method to associate particular genes with focal benefits in both model organism(s) and patients, initial screening of candidate substances can proceed in the model organism(s) using specific assays.

Note: Additional information will be forthcoming following the close of negotiations currently under way.

Recent News

Genescient Receives Additional Angel Funding

Genescient Corporation, a California genomic-health biotechnology company, received $500,000 in new angel investment, to help commercialize the company’s technology and to fund further research.

Read Full Article »

Genescient Chairman to Speak at Singularity Summit 2009

Gregory Benford, Chairman of the Board of Genescient Corporation, will discuss Genescient’s approach to expanded longevity and will discuss some of its latest results, at The Singularity Summit 09.

Read Full Article »

Recent Publications

Adaptation, Aging, and Genomic Information

Aging is not simply an accumulation of damage or inappropriate higher-order signaling. Aging occurs because of the extensive absence of adaptive genomic information

Read Full Article »

Evolution of ageing since Darwin

Evolutionary biology provides the only cogent, formally developed, and experimentally corroborated theory for biological ageing. In this essay, we supply a brisk run through the highlights of evolutionary research on the biology of ageing.

Read Full Article »